2014 J Neurol Neurophysiol

Millier, A. | Briquet, B. | Georges, N. | Murthy, V. | Toumi, M. | Volume: 5, Issue: , Pages: 5, aripiprazole, Schizophrenia, antipsychotic drug, Europe, Safety, France, Germany, Sweden, therapy, https://www.doi.org/http://dx.doi.org/10.4172/2155-9562.1000226